Aristotle Capital Boston, LLC, an investment advisor, released its fourth-quarter investor letter for “Small Cap Equity Fund”. A copy of the letter can be downloaded here. U.S. small-cap equities reported modest gains in the fourth quarter of 2025. The quarter started as a continuation of the post-Liberation Day risk-on market environment, while it ended on a strong note, driven by a positive macroeconomic backdrop. Attractive valuations, earnings recovery, broadening of the market, and a shift from mega-cap stocks supported small caps in the quarter. The Aristotle Small Cap Equity Fund (Class I-2) returned 1.96% in Q4 2025, trailing the 2.19% total return of the Russell 2000 Index. Security selection supported overall performance, while allocation effects detracted from performance. Please review the Strategy’s top five holdings to gain insights into their key selections for 2025.
In its fourth-quarter 2025 investor letter, Aristotle Small Cap Equity Fund highlighted Acadia Healthcare Company, Inc. (NASDAQ:ACHC) as a major performance detractor. Incorporated in 2005, Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is a behavioral healthcare services provider. On February 13, 2026, Acadia Healthcare Company, Inc. (NASDAQ:ACHC) stock closed at $16.77 per share. One-month return of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was 43.58%, and its shares are down 59.16% over the past twelve months. Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has a market capitalization of $1.517 billion.
Aristotle Small Cap Equity Fund stated the following regarding Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in its fourth quarter 2025 investor letter:
“Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is a behavioral healthcare and substance abuse treatment services company. Shares sold off following mixed third quarter earnings results. While earnings beat estimates, management reduced forward guidance, causing the stock to sell-off. The company expects to reduce capex plans and focus on improving the operational strength of the business, which should improve free cash flow. We continue to believe the company is well positioned to be an important part of the solution to an unfortunately growing need for behavioral health services.”
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is not on our list of 30 Most Popular Stocks Among Hedge Funds. According to our database, 40 hedge fund portfolios held Acadia Healthcare Company, Inc. (NASDAQ:ACHC) at the end of the third quarter, up from 39 in the previous quarter. While we acknowledge the potential of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
